Dr. Daniel Kantor talks with Dr. David Irani, Associate Professor of Neurology at the University of Michigan, about developing bio markers in Multiple Sclerosis to help better understand the differences between relapsing and progressive forms.
We Thank Biogen, Mylan, Novartis, Genentech and Mallinckrodt for supporting MSWorld's coverage of ACTRIMS 2016.
We also Thank Biogen, EMD Serono, Mylan, Novartis, Teva, Genentech, Sanofi-Genzyme, Acorda and Mallinckrodt for supporting MSWorld's Overall 2016 Conference Coverage Program.
Information shared here is not for the diagnosis or treatment of any medical condition. For specific information and advice, consult your personal physician.